|
Sep 28
|
The past three years for Harvard Bioscience (NASDAQ:HBIO) investors has not been profitable
|
|
May 16
|
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
|
|
May 8
|
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
|
|
May 7
|
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
|
|
May 7
|
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
|
|
May 7
|
Harvard Bioscience Announces First Quarter 2024 Financial Results
|
|
Apr 29
|
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
|
|
Apr 9
|
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
|
|
Mar 25
|
Investing in Harvard Bioscience (NASDAQ:HBIO) a year ago would have delivered you a 25% gain
|
|
Mar 12
|
Sidoti Events, LLC's Virtual March Small-Cap Conference
|
|
Mar 11
|
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
|
|
Mar 9
|
Is There An Opportunity With Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 34% Undervaluation?
|
|
Mar 8
|
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript
|
|
Mar 8
|
Q4 2023 Harvard Bioscience Inc Earnings Call
|
|
Mar 7
|
Harvard Bioscience Inc (HBIO) Reports Mixed Fourth Quarter and Full Year 2023 Results
|
|
Mar 7
|
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
|
|
Mar 6
|
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
|
|
Nov 8
|
Q3 2023 Harvard Bioscience Inc Earnings Call
|
|
Nov 7
|
Harvard Bioscience Inc (HBIO) Reports Q3 2023 Earnings: Gross Margin Expands Amid Revenue Decline
|